Phase 2 Doxorubicin Clinical Trials
2 recruitingPhase 2
What is a Phase 2 trial?
Phase 2 trials evaluate whether a treatment works for a specific condition and further assess its safety. These studies typically enroll several hundred participants and provide preliminary data on effectiveness.
Showing 1–2 of 2 trials
Recruiting
Phase 2
Evaluation of the Possible Safety and Efficacy of Dapagliflozin in the Prophylaxis of Doxorubicin-Induced Cardiotoxicity
Breast CancerDoxorubicin Induced Cardiomyopathy
Tanta University46 enrolled1 locationNCT06427226
Recruiting
Phase 2
Clinical Study to Evaluate The Cardioprotective Effect of Pentoxifylline Against Doxorubicin Induced Cardiotoxicity in Breast Cancer Patients
Breast CancerDoxorubicin Induced Cardiotoxicity
Tanta University46 enrolled1 locationNCT07137793